# FDA Inspection 1219441 - Yichang Sanxia Pharmaceutical Co., Ltd. - September 08, 2023

Source: https://www.keypedia.com/records/fda_inspections/yichang-sanxia-pharmaceutical-co-ltd/c1e26f52-a48b-403e-a54f-0bff836775e4
Source feed: FDA_Inspections

> FDA inspection 1219441 of Yichang Sanxia Pharmaceutical Co., Ltd., September 08, 2023. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219441
- Company Name: Yichang Sanxia Pharmaceutical Co., Ltd.
- Inspection Date: 2023-09-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 982640 - 2016-07-15
- FDA Inspection 894200 - 2014-08-29
- FDA Inspection 740465 - 2011-06-16
- FDA Inspection 612911 - 2009-07-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/clinton-j-lott/ac4c7d18-13fd-4b1b-b2a1-06794c9960c7)

Company: https://www.keypedia.com/companies/yichang-sanxia-pharmaceutical-co-ltd/087044cf-7161-49c8-8496-3c572bc277d0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c